Eiji Sato

Flagship, Inc. is a wholly-owned subsidiary of es Holdings Co. Ltd., an independent firm formerly affiliated with the outsourcing group Intelligence, and a provider of outsourced business services. Flagship was established in 2007 and is located in Tokyo. The firm manages a venture capital investment fund for institutional clients and provides corporate management consulting services. They operate in close relationship with fellow subsidiaries specialized in payroll, accounting and tax-related services. Their venture capital investment fund, Flagship Fund was established in 2005 in cooperation with Usen Corp. Flagship also cooperates with venture capital specialist Daiwa SMBC Capital Co. Ltd. (formerly NIF SMBC Ventures) on start-up investments and the management of the fund.

Part of Taiyo Holdings Co., Ltd., Taiyo Ink International (Singapore) Pte Ltd. sells printed wiring boards. The company is based in Singapore, Singapore.

Founded in 2001, Taiyo Ink (Suzhou) Co., Ltd. is a subsidiary of Taiyo Holdings Co., Ltd. that manufactures and distributes chemical products. The company is based in Suzhou, China.

Onstatic Technology Co., Ltd. engages in the manufacturing and distribution of solder resist ink used in the printed circuit board production. Its products are divided into categories which include Liquid Photoimageable Solder Resist Ink, Liquid Photoimageable Etching Resist Ink, Thermal Curable Marking Ink, and UV Curable Marking Ink. The company was founded in September 1998 and is headquartered in New Taipei, Taiwan.

Taiyo Ink Manufacturing Co., Ltd. operates as a chemical manufacturer. It develops flat panel display materials, along with a variety of electronic components. The company was founded on August 5, 1999 and is headquartered in Hiki, Japan.

Part of Taiyo Holdings Co., Ltd., Taiyo Green Energy Co., Ltd. generates and distributes solar electric power. The company is based in Hiki, Japan.

Taiyo Pharma Co. Ltd. engages in the development, manufacture and sale of prescription drugs and quasi drugs. The company was founded on August 2, 2017 and is headquartered in Tokyo, Japan.

Part of Taiyo Holdings Co., Ltd., TAIYO Pharma Tech Co., Ltd. is a pharmaceutical company based in Osaka, Japan. TAIYO Pharma Tech Co. specializes in solid formulation manufacturing and aims to provide high-quality products in response to diverse needs in the medical and pharmaceutical business. The Japanese company was founded in 2019. Eiji Sato has been the CEO of the company since 2019.